Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 37,139 $ 31,983
Short-term investments 26,870 48,214
Accounts receivable, net 14,347 9,185
Inventories 73,937 71,202
Contract assets 8,056 6,805
Prepaid expenses and other current assets 4,575 5,533
Total current assets 164,924 172,922
Property and equipment, net 19,075 19,812
Equipment on lease, net 6,672 9,070
Other assets 23,055 23,310
Total assets 213,726 225,114
Current liabilities:    
Accounts payable 10,584 12,207
Accrued expenses and other current liabilities 13,805 15,877
Debt – current portion 2,729 2,775
Contract liabilities 10,611 15,194
Total current liabilities 37,729 46,053
Long-term debt – less current portion 9,756 5,422
Contingent earnout liabilities 27,067 17,414
Warrant liabilities 5,298 2,745
Other noncurrent liabilities 11,936 12,634
Total liabilities 91,786 84,268
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Common stock, $0.00001 par value - 500,000,000 shares authorized at March 31, 2023 and December 31, 2022, 192,479,797 and 187,561,368 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively 2 2
Additional paid-in capital 378,532 361,528
Accumulated other comprehensive loss (549) (837)
Accumulated deficit (256,045) (219,847)
Total stockholders’ equity 121,940 140,846
Total liabilities and stockholders’ equity $ 213,726 $ 225,114